Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131 I Administration.
Cristiane J Gomes-LimaSanjita ChittimojuLeen WehbehSunita DiaPrathyusha PagadalaMohammad Al-JundiSakshi JhawarEshetu A TeferaMihriye MeteJoanna Klubo-GwiezdzinskaDouglas Van NostrandJacqueline JonklaasLeonard WartofskyKenneth D BurmanPublished in: Journal of the Endocrine Society (2022)
As has been shown previously for low-risk DTC, this study indicates that the mode of preparation for RAI therapy does not appear to influence the outcomes of patients with metastatic DTC. PFS and OS were similar for patients with THW-aided or rhTSH-aided RAI therapies.